CVE-2017-18228 Cross-site scripting in n/a
Cross-site scripting in BMC Remedy AR System allows attackers to inject scripts via the ATTKey parameter, potentially leading to session hijacking or code execution.
- Exploited in the wild
- Not known
- Login needed
- Any signed-in user
- Attackable
- Over the internet
- Victim action needed
- A user has to click or open something
- Fix
- None listed
What is CVE-2017-18228?
CVE-2017-18228 is a medium-severity cross-site scripting vulnerability in n/a, published on 12 Mar 2018. Any signed-in user can exploit it over the network, and only if a user opens a file or follows a link.
Official description
Remedy Mid Tier in BMC Remedy AR System 9.1 allows XSS via the ATTKey parameter in an arsys/servlet/AttachServlet request.
Weakness: CWE-79
Which versions are affected by CVE-2017-18228?
It affects 1 product.
Products include Bmc Remedy Action Request System.
How do I fix CVE-2017-18228?
No fix has been published for CVE-2017-18228 yet. Limit exposure of the affected software until one is available.
Escape output for the context it lands in and set a strict Content Security Policy. Upgrading the affected component is the real fix. More about Cross-site scripting.
Is CVE-2017-18228 being exploited?
There is no known exploitation of CVE-2017-18228 in the wild and no public exploit code.
Other vulnerabilities in n/a
Sources
Also known as GHSA-xpwq-6mfc-rr7g.